198 related articles for article (PubMed ID: 16214589)
1. Misleading data analyses in salmeterol (SMART) study.
Lurie P; Wolfe SM
Lancet; 2005 Oct; 366(9493):1261-2; discussion 1262. PubMed ID: 16214589
[No Abstract] [Full Text] [Related]
2. Salmeterol and paroxetine: more evidence for paradoxical medicine.
Yun AJ; Lee PY; Doux JD
Med Hypotheses; 2006; 66(5):1037-8. PubMed ID: 16364562
[No Abstract] [Full Text] [Related]
3. Salmeterol.
Med Lett Drugs Ther; 1994 Apr; 36(921):37-9. PubMed ID: 7909139
[No Abstract] [Full Text] [Related]
4. Salmeterol for the treatment of asthma.
Weinberger M
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
[No Abstract] [Full Text] [Related]
5. Levalbuterol and racemic albuterol: are there therapeutic differences?
Ahrens R; Weinberger M
J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
[No Abstract] [Full Text] [Related]
6. Salmeterol and formoterol: asthma aggravation. Use should be restricted.
Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19743580
[No Abstract] [Full Text] [Related]
7. Life-threatening asthma during treatment with salmeterol.
Weinberger M; Abu-Hasan M
N Engl J Med; 2006 Aug; 355(8):852-3. PubMed ID: 16929006
[No Abstract] [Full Text] [Related]
8. Evidence based answers--is salmeterol safe in asthma?
Spurling G; Doust J
Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
[No Abstract] [Full Text] [Related]
9. Long-acting beta-agonists, tachyphylaxis, and corticosteroids.
Sears MR
Chest; 1996 Apr; 109(4):862-4. PubMed ID: 8635359
[No Abstract] [Full Text] [Related]
10. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
Nelson HS; Berkowitz RB; Tinkelman DA; Emmett AH; Rickard KA; Yancey SW
Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1556-61. PubMed ID: 10228126
[TBL] [Abstract][Full Text] [Related]
11. Beta-agonists, beta-blockers and obstructive airway disease.
Madalena Esteves M
Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
[No Abstract] [Full Text] [Related]
12. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
Fowler SJ; Lipworth BJ
JAMA; 2001 Dec; 286(24):3076-7; author reply 3077-8. PubMed ID: 11754665
[No Abstract] [Full Text] [Related]
13. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
Miller FG; Shorr AF
JAMA; 2001 Dec; 286(24):3075-6; author reply 3077-8. PubMed ID: 11754663
[No Abstract] [Full Text] [Related]
14. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
Friedman Ross L
JAMA; 2001 Dec; 286(24):3076; author reply 3077-8. PubMed ID: 11754664
[No Abstract] [Full Text] [Related]
15. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
Botkin JR; Clayton E; Nelson R; Wilfond B; Munger MA
JAMA; 2001 Dec; 286(24):3075; author reply 3077-8. PubMed ID: 11754662
[No Abstract] [Full Text] [Related]
16. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
Boyd G
Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
[TBL] [Abstract][Full Text] [Related]
17. Excess mortality in patients with asthma on long-acting beta2-agonists.
Hasford J; Virchow JC
Eur Respir J; 2006 Nov; 28(5):900-2. PubMed ID: 17074917
[No Abstract] [Full Text] [Related]
18. Labeling changes for asthma drug salmeterol.
FDA Consum; 2003; 37(6):6. PubMed ID: 14983813
[No Abstract] [Full Text] [Related]
19. [Serevent in the treatment of moderate bronchial asthma].
Panghea P; Voicu G; Filip G; Arghir O; Floca L; Acasandri E; Mihai D
Pneumoftiziologia; 1996; 45(3-4):145-8. PubMed ID: 9221040
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol xinafoate in asthma.
Palmer JB; Oxford JM
JAMA; 1994 Nov 23-30; 272(20):1575-6. PubMed ID: 7966861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
